Common Contracts
2 similar Preferred Stock Purchase Agreement contracts by SCP Private Equity Partners Ii Lp, Xcyte Therapies Inc
WHEREAS, the Corporation plans to issue and sell up to 75,000 shares of the Parent's Series C-1 Preferred Stock, par value $0.01 per share ("Series ------ C-1 Stock"), to SCP at a purchase price of $40.00 per share and to issue to SCP --------- a...Preferred Stock Purchase Agreement • April 9th, 2001 • SCP Private Equity Partners Ii Lp • Services-prepackaged software
1 EXHIBIT 10.4 XCYTE THERAPIES, INC. SECOND ADDENDUM TO SERIES D PREFERRED STOCK PURCHASE AGREEMENT This Second Addendum to Series D Preferred Stock Purchase Agreement (the "Second Addendum") is made as of the 14th day of August, 2000 by and among...Preferred Stock Purchase Agreement • December 22nd, 2000 • Xcyte Therapies Inc
